Whitestone Holding acquired a 28% stake in Telemis, a profitable medical imaging management company, for €9.1 million, further solidifying its position in the growing medtech sector.

Target Information

Founded in 1999 as a spin-off from UCL, Telemis is a medical imaging management company that has garnered significant attention in the medtech sector. Recently, Whitestone Holding acquired a one-third stake in the company, further strengthening its presence in the healthcare technology arena. Post acquisition of Lambda-X Ophthalmics, Whitestone continues its focus on expanding within the medtech industry.

Whitestone's investment includes the purchase of 28% of Telemis's shares from three minority shareholders for €9.1 million. With Telemis holding 8.9% of its own shares, Whitestone's effective stake in the company is bound to exceed this percentage. Notably, Telemis's CEO and founder, Stephane Ketelaer, remains the majority shareholder, indicating a strong leadership commitment to the company's direction.

Industry Overview

The medtech sector in Belgium has shown robust growth, driven by technological advancements and an increasing demand for healthcare services due to the aging population. Companies within this